EpiCapture

EpiCapture, a health care startup founded in 2021, aims to revolutionize cancer patient care with precise, non-invasive urine tests for detecting aggressive cancers. The company's slogan, "Enhancing cancer patient care with precise, non-invasive urine tests for detecting aggressive cancers," encapsulates its mission. EpiCapture recently secured a grant investment on 21 April 2023 from the Department of Enterprise, Trade and Employment, signaling confidence in its innovative approach. By focusing on the development of accurate, non-invasive urine tests for the early detection of aggressive cancers, EpiCapture has positioned itself at the forefront of the health care industry. With this recent investment, the company is poised to make significant strides in improving cancer diagnostics and patient outcomes.

EpiCapture's dedication to leveraging non-invasive technology to enhance cancer detection addresses a critical need in the health care sector. Through its innovative approach, EpiCapture has garnered support from the Department of Enterprise, Trade and Employment, underscoring the confidence in its potential to make a meaningful impact. As the company continues to advance its non-invasive urine tests, the recent grant investment provides a strong foundation for growth and development.